Astellas announces acquisition of Quethera for £85 million
Astellas Pharma and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom, that is focused on developing novel treatments for ocular disorders, such as glaucoma. August 10, 2018